Labcorp Unveils Whole Health Solutions For Functional And Integrative Medicine Providers

June 18, 2025 08:23 PM PDT | By EODHD

Google News:

Labcorp Unveils Whole Health Solutions For Functional And Integrative Medicine Providers — Image source: Kalkine Media

Recent News

Estée Lauder (NYSE:EL) Stock Gains As Leadership Strategy NYSE Composi...

Oceaneering International Earnings Growth Shows Positive Signs for (NY...

JPMorgan (NYSE:JPM) Chase Fixed Strengthen Experience Dow Jones Indust...

Realty Strengthens (NYSE:O) Financial Position NYSE Composite

(RTTNews) - Labcorp (LH) has launched Labcorp Whole Health Solutions, a comprehensive testing initiative designed to support functional, integrative, and primary care providers in delivering holistic, personalized care. The program introduces specialized test panels and a curated menu of over 1,000 scientifically validated biomarkers targeting cardiometabolic health, hormones, micronutrients, longevity, and full-body wellness. Driven by the rising demand for integrative and functional healthcare approaches—used by approximately 122 million U.S. adults in 2022, according to NIH data—Labcorp is responding to the shift with expanded diagnostic offerings. The company has seen steady growth in the number of such practitioners it serves.

Dr. Brian Caveney, Chief Medical and Scientific Officer at Labcorp, stated that the new solution aims to empower providers with accessible, science-backed diagnostics to better understand and manage patient health through a holistic lens. Key offerings include seven specialized test panels designed to provide comprehensive health insights: the Advanced Cardiometabolic Biomarker Panel, Comprehensive Nutrient Panel, Longevity and Vitality Panel, Men's and Women's Comprehensive Hormone Panels, and Men's and Women's Whole Body Wellness Panels. These panels aim to support personalized care by addressing critical areas of health and wellness through a holistic diagnostic approach. Patients can have specimens collected either through their provider or at any of Labcorp's 2,200+ patient service centers nationwide.

Wednesday, LH closed at $261.39, up 0.75%, and edged slightly higher in after-hours trading to $261.40 on the NYSE.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.